The abdominal aortic aneurysm treatment market is set to witness a steady growth trajectory, expanding at a modest compound annual growth rate (CAGR) of 5.82% throughout the forecast period. From a valuation of USD 2.06 billion in 2022, the market is expected to reach USD 3.63 billion by 2032, driven by a combination of demographic, technological, and healthcare developments.
Several factors are contributing to the anticipated growth of the abdominal aortic aneurysm treatment market:
- Aging Population: As the global geriatric population continues to grow, the incidence of abdominal aortic aneurysms is expected to rise, prompting an increased demand for effective treatment options.
- Prevalence of Associated Conditions: The growing prevalence of conditions such as atherosclerosis, syphilis, and medical cystic necrosis, all of which are linked to an increased risk of AAA, is further driving market expansion.
- Technological Advancements and Device Reimbursement: Advances in medical technologies and improved reimbursement for medical devices are enabling better treatment options and accessibility, supporting market growth.
- Rising Healthcare Costs: While healthcare costs continue to rise, advancements in AAA treatments and the growing emphasis on cost-effective solutions are anticipated to fuel the market.
- Hypertension and Hyperlipidaemia: Increasing rates of hypertension and hyperlipidaemia, two leading risk factors for AAA, are expected to be a significant driver in the market.
- Growing Incidence Among Smokers: The rising number of elderly male smokers who are at higher risk for AAA, especially those requiring ultrasound screening alongside CT scans, is further propelling market growth.
The abdominal aortic aneurysm treatment market remains dynamic as the healthcare sector continues to evolve. Stakeholders, including medical device manufacturers, healthcare providers, and researchers, are anticipated to play a key role in shaping the future of AAA treatment by focusing on innovation, patient accessibility, and addressing the challenges posed by an aging population.
Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!
Abdominal Aortic Aneurysm Treatment Market: Regional Overview
The global Abdominal Aortic Aneurysm (AAA) Treatment Market is experiencing significant growth, driven by increasing awareness of AAA risk factors and advancements in treatment options.
North America
North America dominates the market, particularly the U.S., due to high prevalence rates, a robust healthcare infrastructure, and a growing aging population. The adoption of minimally invasive treatments like endovascular aneurysm repair (EVAR) is expanding.
Europe
Europe holds a substantial share, with a focus on both surgical and endovascular approaches. Countries like Germany, France, and the UK have well-established healthcare systems that contribute to the high demand for AAA treatments.
Asia-Pacific
The Asia-Pacific region is seeing rapid growth, fueled by rising healthcare investments and improvements in diagnostic capabilities. However, adoption of advanced AAA treatments remains slower compared to Western markets.
Latin America and Middle East & Africa
In these regions, the market is expanding gradually due to increased awareness and healthcare reforms. Yet, access to advanced treatment options may be limited by economic factors and infrastructure constraints.
Overall, the AAA treatment market is expanding globally, with varying adoption rates across regions based on healthcare advancements and access to treatment options.
Abdominal Aortic Aneurysm Treatment Market: Key Players
Some of the key players in the abdominal aortic aneurysm treatment market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Abbott, AbbVie Inc., Celgen Corporation, Amgen Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc.,Sanofi, GlaxoSmithKline Pharmaceuticals Limited and Mylan N.V.
Abdominal Aortic Aneurysm Treatment Market: Segmentation
The global abdominal aortic aneurysm treatment market has been classified on the basis of treatment, end use and geography.
Based on treatment, the global abdominal aortic aneurysm treatment market is divided into following:
- Surgery
- Open surgery
- Endovascular aneurysm
- Medication
- Antihypertensive
- Antilipidemics
Based on end user type, the global abdominal aortic aneurysm treatment market is divided into following:
- Hospitals
- Clinics
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube